Detection and interpretation of altered methylation patterns in cancer cells
The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Epigenetic alterations, such as abnormal DNA-methylation patterns, are associated with many human tumour types. New techniques have been developed to perform genome-wide screening for alterations in DNA-methylation patterns, not only to identify tumour-suppressor genes, but also to find patterns that can be used in diagnosis and prognosis. However, interpretation of differential methylation has proven difficult because the significance of methylation alterations depends on the genomic region, and functions of CpG islands at specific sites have not been fully clarified. What techniques can be used to identify new tumour suppressors and diagnostic markers?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ROS influence the activity of epigenetic modulators, such as histone deacetylases (HDACs) or DNA methyltransferases (DNMTs) with consequences that are evident in the expression of the target genes38,39.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [39]
Citations
Cites
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
CpG Islands in vertebrate genomes
Gardiner-Garden, M., & Frommer, M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90689-9 · Cited by 3,353
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., & Herman, J. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431901 · Cited by 2,224
Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene
Bell, A. C., & Felsenfeld, G. (2000) · Nature · doi:10.1038/35013100 · Cited by 1,746 · cited 1×
“), and defines regions for transcriptional regulatio”
Cited by
Items 201–300 of 482
The Role of Vimentin as a Methylation Biomarker for Early Diagnosis of Cervical Cancer
Jung, S., Yi, L., Kim, J., Jeong, D., Oh, T., Kim, C., Kim, C., Shin, J., An, S., & Lee, M. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0229-x · Cited by 41
“It is well known that the transcription of several key tumor suppressor genes is found to be inactivated by promoter hypermethylation in many cancer cells (Baylin and Ohm, 2006; Egger et al., 2004; Esteller et al., 2001; Issa, 2004; Ushijima, 2005).”
BackgroundEpigenetic DNA hypermethylation: Clinical applications in endometrial cancer (Review)
Banno (2009) · Oncology Reports · doi:10.3892/or_00000523 · Cited by 48
Honda, S., Minato, M., Suzuki, H., Fujiyoshi, M., Miyagi, H., Haruta, M., Kaneko, Y., Hatanaka, K. C., Hiyama, E., Kamijo, T., et al. (2016) · Cancer Science · doi:10.1111/cas.12928 · Cited by 40
Development of Oxidation Damage Base-Based Fluorescent Probe for Direct Detection of DNA Methylation
Zhang, Y., Li, C.-C., Zhang, X., Xu, Q., & Zhang, C. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c01880 · Cited by 40
Tahara, T., Arisawa, T., Shibata, T., Wang, F. Y., Nakamura, M., Sakata, M., Nagasaka, M., Takagi, T., Kamiya, Y., Fujita, H., et al. (2007) · Digestion · doi:10.1159/000101775 · Cited by 40
Quantitative analysis of promoter methylation of the EDNRB gene in gastric cancer
Tao, K., Wu, C., Wu, K., Li, W., Han, G.-X., Shuai, X., & Wang, G. (2011) · Medical Oncology · doi:10.1007/s12032-010-9805-8 · Cited by 39
“For these reasons, detection of epigenetic aberrations in cancer lesions is important in cancer research [22].”
BackgroundGhantous, A., Hernández‐Vargas, H., Byrnes, G. B., Dwyer, T., & Herceg, Z. (2015) · Mutagenesis · doi:10.1093/mutage/gev010 · Cited by 40
Borges, B. D. N., Santos, E. D. S., Bastos, C. E. M. C., Pinto, L. C., Anselmo, N. P., Quaresma, J. A. S., Calcagno, D. Q., Burbano, R. M. R., & Harada, M. L. (2010) · PubMed · Cited by 38
Yamashita, S., Hosoya, K., Gyobu, K., Takeshima, H., & Ushijima, T. (2009) · DNA Research · doi:10.1093/dnares/dsp017 · Cited by 42
Self-citationRaut, J. R., Guan, Z., Schrotz‐King, P., & Brenner, H. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00904-7 · Cited by 39
Herceg, Z., & Ushijima, T. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380866-0.60001-0 · Cited by 40
“By analogy, deregulation of epigenetic mechanisms has been associated with a variety of human diseases, most notably cancer (Egger et al., 2004; Feinberg and Tycko, 2004; Feinberg et al., 2006; Jones and Baylin, 2002; Ushijima, 2005).”
BackgroundSelf-citationLiu, J.-W., Nagpal, J. K., Sun, W., Lee, J., Kim, M. S., Ostrow, K. L., Zhou, S., Jerónimo, C., Henrique, R., Criekinge, W. V., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4763 · Cited by 36
Zhang, X., Yang, X., Wang, J., Liang, T., Gu, Y., & Yang, D. (2015) · PubMed Central · Cited by 35
Andersen, G. B., & Tost, J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7481-8_1 · Cited by 39
Bücker, L., & Lehmann, U. (2022) · Cancers · doi:10.3390/cancers14184377 · Cited by 41
“Subsequently, it can be analyzed in qualitative and quantitative terms employing a wide range of molecular techniques developed for the detection of single nucleotide variants [29,30].”
BackgroundAberrant DNA methylation and tumor suppressive activity of the EBF3 gene in gastric carcinoma
Kim, J., Min, S. Y., Lee, H. E., & Kim, W. H. (2011) · International Journal of Cancer · doi:10.1002/ijc.26038 · Cited by 35
“EBF3 methylation in gastric cancer tissues deserves further attention as a potential diagnostic biomarker because tumor suppressor genes show high frequencies of promoter hypermethylation in primary cancer tissues, but not in normal tissues.(27) In our study, we performed MSP on 104 gastric cancer tissues to document…”
BackgroundLee (2010) · Oncology Reports · doi:10.3892/or_00001067 · Cited by 35
Brotons, A., Vidal‐Iglesias, F. J., Solla‐Gullón, J., & Iniesta, J. (2015) · Analytical Methods · doi:10.1039/c5ay02616d · Cited by 35
High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes
Abe, M., Yamashita, S., Mori, Y., Abe, T., Saijo, H., Hoshi, K., Ushijima, T., & Takato, T. (2016) · BMC Cancer · doi:10.1186/s12885-016-2371-5 · Cited by 35
“As a molecular marker to identify lesions with a higher risk of malignant transformation, DNA methylation might be useful [10–14].”
BackgroundSelf-citationIdentification of differentially methylated regions in new genes associated with knee osteoarthritis
Bonin, C. A., Lewallen, E. A., Baheti, S., Bradley, E. W., Stuart, M. J., Berry, D. J., van Wijnen, A. J., & Westendorf, J. J. (2015) · Gene · doi:10.1016/j.gene.2015.10.037 · Cited by 35
Sato, A., Yamada, N., Ogawa, Y., & Ikegami, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057013 · Cited by 34
“region for DNA silencing in cancer cells [21,22], the methylation”
BackgroundPark, J. K., Ryu, J. K., Lee, K. H., Lee, J. K., Yoon, W. J., Lee, S. H., Yoo, J. W., Woo, S. M., Lee, G. Y., Lee, C. H., et al. (2007) · Pancreas · doi:10.1097/mpa.0b013e318153fa42 · Cited by 34
“One of these epigenetic alterations is aberrant DNA methylation, which involves promoter CpG island methylation and silences genes.(10,11) Recently, Sato et al(12) reported that UCHL1, NPTX2, SARP2, CLDN5, reprimo, LHX1, WNT7A, FOXE1, TJP2, CDH3, and ST14 are aberrantly methylated in primary pancreatic cancer tissue.”
BackgroundEpigenetic biomarkers in urothelial bladder cancer
Kim, W., & Kim, Y. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.5 · Cited by 35
Clinical characteristics of hepatocellular carcinoma in elderly patients
Miyaaki, H. (2011) · Oncology Letters · doi:10.3892/ol.2011.359 · Cited by 35
Li, W., & Xu, L. (2019) · Oncology Research and Treatment · doi:10.1159/000498947 · Cited by 35
Pero, R., Angrisano, T., Brancaccio, M., Falanga, A., Lombardi, L., Natale, F., Laneri, S., Lombardo, B., Galdiero, S., & Scudiero, O. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222295 · Cited by 39
“Also, several CpG islands (CGI) and, even inside a CGI, diverse regions show different susceptibilities to aberrant DNA methylation [62], and analysis considering the different susceptibilities has not been done.”
BackgroundNakase, K., Cheng, J., Zhu, Q. K., & Marasco, W. A. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0608383 · Cited by 36
“This supports the notion that SHP-1 P2 LC is a pivotal region for transcription, as methylation of only a core region covering the transcription start site is associated consistently with gene silencing [35].”
BackgroundHeterogeneity of Human Glioblastoma: Glutathione-S-Transferase and Methylguanine-Methyltransferase
Juillerat‐Jeanneret, L., Bernasconi, C. C., Bricod, C., Gros, S., Trepey, S., Benhattar, J., & Janzer, R. C. (2008) · Cancer Investigation · doi:10.1080/07357900802072913 · Cited by 35
“EA 28 30 32 35 34 13 O6-BG+carm 56(43) 59(50) 41(32) 35(28) 49(33) 17(4) EA+carm 49(64) 66(75) 52(54) 29(45) 57(57) 8(13) O6-BG+alk 60(75) 60(75) 35(32) 15(22) 24(18) 9(4) EA+alk 64(75) 59(65) 41(50) 40(39) 42(41) 23(13)”
BackgroundMethylation-specific digital karyotyping
Hu, M., Yao, J., & Polyák, K. (2006) · Nature Protocols · doi:10.1038/nprot.2006.278 · Cited by 35
The Emerging Role of Estrogens in Thyroid Redox Homeostasis and Carcinogenesis
de Faria, C. C., Peixoto, M. S., de Carvalho, D. P., & Fortunato, R. S. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2514312 · Cited by 38
“, p15INK4B and p16INK4A) can be silenced by oxidative-induced aberrant CpG island promoter methylation [71, 72].”
BackgroundMa, J., Wang, J., Zhang, W., Zou, B., Chen, W., Lam, C. S. C., Chen, M., Pang, R. W. C., Tan, V. P. Y., Hung, I. F., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq140 · Cited by 34
“It results in the transcriptional silencing of these genes and promotes tumor development [1-4].”
Kikuyama, M., Takeshima, H., Kinoshita, T., Okochi‐Takada, E., Wakabayashi, M., Akashi‐Tanaka, S., Ogawa, T., Seto, Y., & Ushijima, T. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.016 · Cited by 32
Self-citationHypermethylatedFAM5CandMYLKin Serum as Diagnosis and Pre-Warning Markers for Gastric Cancer
Chen, L., Su, L., Li, J., Zheng, Y., Yu, B., Yu, Y., Yan, M., Gu, Q., Zhu, Z., & Liu, B. (2012) · Disease Markers · doi:10.1155/2012/473251 · Cited by 31
Xu, S. B., Liu, X. H., Li, B. H., Zhang, Y., Yuan, J., Yuan, Q., Li, P. D., Yang, X. Z., Li, F., & Zhang, W. J. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0627-z · Cited by 31
Association between frequent CpG island methylation and HER2 amplification in human breast cancers
Terada, K., Okochi‐Takada, E., Akashi‐Tanaka, S., Miyamoto, K., Taniyama, K., Tsuda, H., Asada, K., Kaminishi, M., & Ushijima, T. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp021 · Cited by 31
Self-citationMethylation of p16INK4a Is a Non-Rare Event in Cervical Intraepithelial Neoplasia
Kang, S., Jung-Sik, K., Kim, H. B., Shim, J. W., Nam, E., Kim, S. H., Ahn, H. J., Choi, Y. P., Ding, B., Song, K., et al. (2006) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200606000-00003 · Cited by 31
“Samples with MSP+/IHC results could be ‘‘false-positives’’, genes that should be silenced by methylation, but in reality, are not.(38) Because of the FIGURE 3.”
BackgroundSharif, S. B., Hashemzadeh, S., Ardehaie, R. M., Eftekharsadat, A., Ghojazadeh, M., Mehrtash, A., Estiar, M. A., Teimoori‐Toolabi, L., & Sakhinia, E. (2016) · Oncology Letters · doi:10.3892/ol.2016.5327 · Cited by 30
“Aberrant DNA methylation is one of the best known and well‐defined epigenetic changes in tumors, and is a frequent mechanism for inappropriate gene silencing among tumor suppressor genes (12-14).”
Backgroundα-Internexin: A Novel Biomarker for Pancreatic Neuroendocrine Tumor Aggressiveness
Liu, B., Tang, L. H., Liu, Z., Mei, M., Yu, R., Dhall, D., Qiao, X., Zhang, T., Zhao, Y.-P., Liu, T., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2874 · Cited by 30
The Central Nervous Mechanism of Stress-Promoting Cancer Progression
Hong, Y., Zhang, L., Liu, N., Xu, X., Liu, D., & Tu, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012653 · Cited by 36
Hattori, N., Liu, Y.-Y., & Ushijima, T. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3331-1_13 · Cited by 29
Self-citationKamiyama, H., Noda, H., Takata, O., Suzuki, K., Kawamura, Y., & Konishi, F. (2009) · Journal of Surgical Oncology · doi:10.1002/jso.21291 · Cited by 29
Banelli, B., Bonassi, S., Casciano, I., Mazzocco, K., Vinci, A. D., Scaruffi, P., Brigati, C., Allemanni, G., Borzì, L., Tonini, G. P., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24768 · Cited by 29
“In the last 5 years the interest for the utilization of epigenetic signatures for the molecular diagnostics and for the early detection of cancer has steadily increased.(11,12,39,40) In this respect, many qualitative or semiquantitative studies have shown that hypermethylation is a characteristic of the most aggressiv…”
BackgroundPröll, J., Födermayr, M., Wechselberger, C., Pammer, P., Sonnleitner, M., Zach, O., & Lutz, D. (2006) · DNA Research · doi:10.1093/dnares/dsi024 · Cited by 29
“A variety of methods for the analysis of CpG methylation status have been developed including chromatographic separation, use of methylation-sensitive restriction enzymes and bisulfite-driven conversion of non-methylated cytosine to uracil.(5) Despite the widespread application of the latter and the ongoing technical…”
Li, Y., PAN, P., QIAO, P., & Liu, R. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3086 · Cited by 28
“There are four CGIs which may occur aberrant methylation was significantly higher than the other groups.”
BackgroundInfluentialSuzuki, H., Toyota, M., Kondo, Y., & Shinomura, Y. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-530-9_5 · Cited by 28
“In that context, a number of genome-wide methylation screening techniques have been developed to identify aberrantly methylated genes in cancer (3, 15, 16).”
BackgroundKamal, K. M., Ghazali, A. R., Mutalib, N. A., Abu, N., Chua, E. W., & Masre, S. F. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38663 · Cited by 33
Altered mucosal DNA methylation in parallel with highly active Helicobacter pylori-related gastritis
Yoshida, T., Kato, J., Maekita, T., Yamashita, S., Enomoto, S., Ando, T., Niwa, T., Deguchi, H., Ueda, K., Inoue, I., et al. (2013) · Gastric Cancer · doi:10.1007/s10120-012-0230-x · Cited by 36
“CGI hypermethylation occurs within promoter CGIs and is often associated with a loss of protein expression by transcription repression [19].”
BackgroundSelf-citationNanosized graphene sheets induced high electrochemical activity in pure carbon film
Huang, L., Cao, Y., & Diao, D. (2018) · Electrochimica Acta · doi:10.1016/j.electacta.2018.01.027 · Cited by 27
Bover, A. G., Hernández‐López, R., Alorda-Clara, M., de la Rosa, J. M. I., Falcó, E., Fernández, T., Torrens‐Mas, M., Roca, P., Oliver, J., Sastre‐Serra, J., et al. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105698 · Cited by 29
Uncoupling of promoter methylation and expression of Period1 in cervical cancer cells
Hsu, M., Huang, C., Choo, K., & Huang, C.-J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.042 · Cited by 28
DNA hypermethylation in lung cancer is targeted at differentiation-associated genes
Helman, E., Naxerova, K., & Kohane, I. S. (2011) · Oncogene · doi:10.1038/onc.2011.307 · Cited by 26
“Consequently, genepromoter hypermethylation has become central to developing strategies for molecular screening, treatment and prognosis in a variety of cancers types (Tsou et al., 2002; Laird, 2003; Belinsky, 2004; Safar et al., 2005; Ushijima, 2005).”
BackgroundCIMPle origin for promoter hypermethylation in colorectal cancer?
Schuebel, K. E., Chen, W., & Baylin, S. B. (2006) · Nature Genetics · doi:10.1038/ng0706-738 · Cited by 26
Methylation of the BIN1 gene promoter CpG island associated with breast and prostate cancer
Kuznetsova, E., Kekeeva, T. V., Ларин, С. С., Zemlyakova, V. V., Khomyakova, A. V., Бабенко, О. В., Nemtsova, M. V., Zaletaev, D. V., & Strelnikov, V. V. (2007) · Journal of Carcinogenesis · doi:10.1186/1477-3163-6-9 · Cited by 27
“It has not yet been established, however, whether or not the core region should always contain the minimum promoter and the transcription start site [18].”
BackgroundFast and precise detection of DNA methylation with tetramethylammonium-filled nanopore
Wang, Y., Zhang, Y., Guo, Y., & Kang, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-00317-2 · Cited by 24
Methylation of Multiple Genes in Gastric Glands with Intestinal Metaplasia
Mihara, M., Yoshida, Y., Tsukamoto, T., Inada, K., Nakanishi, Y., Yagi, Y., Imai, K., Sügimura, T., Tatematsu, M., & Ushijima, T. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060552 · Cited by 26
Self-citationEpigenetic Effects of Electroconvulsive Seizures
de Jong, J. O. Z., Arts, B. M. G., Boks, M. P., Sienaert, P. A., van den Hove, D., Kenis, G., van Os, J., & Rutten, B. P. F. (2014) · Journal of Ect · doi:10.1097/yct.0000000000000141 · Cited by 25
Integrated analysis of DNA methylation and mutations in esophageal squamous cell carcinoma
Kishino, T., Niwa, T., Yamashita, S., Takahashi, T., Nakazato, H., Nakajima, T., Igaki, H., Tachimori, Y., Suzuki, Y., & Ushijima, T. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22452 · Cited by 25
“region for transcriptional silencing [12], and the”
MethodSelf-citationIwabu, J., Yamashita, S., Takeshima, H., Kishino, T., Takahashi, T., Oda, I., Koyanagi, K., Igaki, H., Tachimori, Y., Daiko, H., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50005-6 · Cited by 25
Self-citationGadgil, M. S., Joshi, K., Naik, S. S., Pandit, A. N., Otiv, S., & Patwardhan, B. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.879702 · Cited by 28
“methylation EIA kit [12] which measures 5-methyl-20-”
DNA methylation analysis in constitutional disorders: Clinical implications of the epigenome
Schenkel, L. C., Rodenhiser, D. I., Ainsworth, P., Paré, G., & Sadiković, B. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1113496 · Cited by 27
Huang, H.-H., Ji, Y., Zhang, J., Su, Z., Liu, M., Tong, J., Ge, C., Chen, T., & Li, J. (2017) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2017.1384156 · Cited by 25
“Various investigators reported the occurrence of abnormal DNA methylation, hypo- and/or hypermethylation present in lung cancer (Kanai and Hirohashi 2007; Ting, McGarvey, and Baylin 2006; Ushijima 2005).”
BackgroundDownregulation and antiproliferative role of fhl3 in breast cancer
Niu, C., Yan, Z., Cheng, L., Zhu, J., Zhang, H., Xu, X., Lin, J., & Ye, Q. (2011) · IUBMB Life · doi:10.1002/iub.502 · Cited by 23
“In addition, promoter hypermethylation is frequently associated with the silencing of gene expression (34).”
BackgroundMatsumura, S., Oue, N., Mitani, Y., Kitadai, Y., & Yasui, W. (2007) · International Journal of Cancer · doi:10.1002/ijc.22433 · Cited by 24
“It is known that only methylation of a small region within a promoter CpG islands can repress gene transcription.(42) Methylation of Exon 1 or a far upstream region can be associated with loss of transcription, but usually does not have a causal role in transcriptional repression.”
BackgroundNiwa, T., Yamashita, S., Tsukamoto, T., Kuramoto, T., Nomoto, T., Wakazono, K., Fujita, H., Matsushima, T., Tatematsu, M., Sügimura, T., et al. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00068.x · Cited by 24
Self-citationComprehensive DNA Methylation and Extensive Mutation Analyses of HER2-Positive Breast Cancer
Yamaguchi, T., Mukai, H., Yamashita, S., Fujii, S., & Ushijima, T. (2015) · Oncology · doi:10.1159/000369904 · Cited by 25
Self-citationKim, C. W., Kim, H., Kim, H. R., Kye, B., Kim, H. J., Min, B. S., Oh, T. J., An, S., & Lee, S.-H. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01759-9 · Cited by 23
“Therefore, the presence of methylation of specific genes could be used as a biomarker for the diagnosis of early-stage cancer [14].”
BackgroundYokoyama, S., Kitamoto, S., Yamada, N., Houjou, I., Sugai, T., Nakamura, S., Arisaka, Y., Takaori, K., Higashi, M., & Yonezawa, S. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-67 · Cited by 24
“Furthermore, abnormal epigenetic changes appear to be early “seeds of methylation” that precede detection of genetic mutations [11,12].”
BackgroundMeng, X., Xu, Z., Wang, M., Yin, H., & Ai, S. (2013) · Electrochimica Acta · doi:10.1016/j.electacta.2013.02.050 · Cited by 23
Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling
Matthew, E. M., Yang, Z., Peri, S., Andrake, M., Dunbrack, R. L., Ross, E. A., & El‐Deiry, W. S. (2018) · Neoplasia · doi:10.1016/j.neo.2018.01.004 · Cited by 24
“Epigenetic alterations are one of the early events in colon tumorigenesis [30,56,57].”
BackgroundInfluentialHypermethylation of the COX‐2 gene is a potential prognostic marker for cervical cancer
Jo, H., Kang, S., Kim, J., Kang, G. H., Park, N. H., Song, Y. S., Park, S. Y., Kang, S. B., & Lee, H. P. (2007) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2007.00517.x · Cited by 23
Experimental approaches to the study of epigenomic dysregulation in ageing
Thompson, R. F., Fazzari, M. J., & Greally, J. M. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2009.12.013 · Cited by 27
“Current analytical advances allow rapid interpretation of methylation data from RLGS (Wimmer et al., 2002), and the accuracy of this technique has been proven, however it remains a technical challenge to perform and generates limited amounts of data (Ushijima, 2005).”
BackgroundNovel markers of gene methylation and expression in breast cancer
Kuznetsova, E., Kekeeva, T. V., Ларин, С. С., Zemlyakova, V. V., Бабенко, О. В., Nemtsova, M. V., Zaletaev, D. V., & Strelnikov, V. V. (2007) · Molecular Biology · doi:10.1134/s0026893307040061 · Cited by 22
“Genome-wide screening of differential methylation is a potent method to search for new genes involved in carcinogenesis and establishing efficient markers of carcinogenesis [5].”
MethodKondo, M., Aboshi, H., Yoshikawa, M., Ogata, A., Murayama, R., Takei, M., & Aizawa, S. (2020) · Journal of Oral Science · doi:10.2334/josnusd.20-0138 · Cited by 26
“The method has often been applied for the diagnosis of inherited diseases and various types of cancer [29,30].”
MethodEpigenetic regulation of the potential tumor suppressor gene, hLHX6.1, in human cervical cancer
Lee (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.904 · Cited by 22
Comparing the DNA Hypermethylome with Gene Mutations in Human Colorectal Cancer
Schuebel, K. E., Chen, W., Cope, L., Glöckner, S. C., Suzuki, H., Yi, J. M., Chan, T. A.-T., Neste, L. V., Criekinge, W. V., van den Bosch, S., et al. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0030157.eor · Cited by 18
Yoon, H. Y., Kim, S., Kim, Y., Kang, H. W., 이상철, Ryu, K. H., Shon, H. S., Kim, W.-J., & Kim, Y.-J. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112444445 · Cited by 21
“Several factors may explain these discrepancies, including differences in sample types, analytical methods, or PCR methods.(3,4) Accordingly, the focus has now shifted to those aberrant methylation events that are absent in normal cells and to the development of techniques that provide reliable, sensitive, and fast re…”
BackgroundInfluentialPromoter methylation blocks FES protein‐tyrosine kinase gene expression in colorectal cancer
Shaffer, J. M., & Smithgall, T. E. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20638 · Cited by 21
“However, when promoter CpG islands become hypermethylated, transcription of downstream genes is often compromised (Ushijima, 2005; Baylin and Ohm, 2006).”
BackgroundYakabe, S., Soejima, H., Yatsuki, H., Tominaga, H., Wei, Z., Higashimoto, K., Joh, K., Kudo, S., Miyazaki, K., & Mukai, T. (2008) · Genes & Genetic Systems · doi:10.1266/ggs.83.199 · Cited by 23
“Since a CGI covering the transcription initiation site (promoter CGI) is usually important for gene repression due to DNA methylation (Ushijima, 2005), we searched for the locations of CGIs in each gene using CpG Island Searcher (http://www.cpgislands.com/), applying the criteria of Takai and Jones…”
MethodInfluentialBaba, Y., Hara, Y., Toihata, T., Kosumi, K., Iwatsuki, M., Iwagami, S., Miyamoto, Y., Yoshida, N., Komohara, Y., & Baba, H. (2023) · Esophagus · doi:10.1007/s10388-023-01009-9 · Cited by 23
“Methylation of this promoter is a key predictor of whether alkylating agents can effectively control tumor cell progression [26].”
BackgroundMicroarray-based DNA methylation study of Ewing’s sarcoma of the bone
Park, H., Jung, W., KIM, H.-S., & Park, Y.-K. (2014) · Oncology Letters · doi:10.3892/ol.2014.2322 · Cited by 20
“Aberrant DNA methylation has been recognized as an early event in tumorigenesis (4,5) and therefore, variations in the methylation patterns identified between normal and tumor cells may aid in the detection of tumor cells in biopsy specimens or tumor‑derived DNA in body fluids (6).”
Qualitative and Quantitative Polymerase Chain Reaction-Based Methods for DNA Methylation Analyses
Wong, I. H. N. (2006) · Humana Press eBooks · doi:10.1385/1-59745-074-x:33 · Cited by 20
Lu, Z., Zhou, J., Wang, X., Guan, Z., Bai, H., Liu, Z., Su, N., Pan, K., Ji, J., & Deng, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035928 · Cited by 21
“Various CpG islands, as well as different regions within the same CpG island, show different degrees of susceptibility to methylation [36].”
Harada, H., Miyamoto, K., Yamashita, Y., Nakano, K., Taniyama, K., Miyata, Y., Ohdan, H., & Okada, M. (2013) · Cancer · doi:10.1002/cncr.27754 · Cited by 19
Zong, L., Hattori, N., Yasukawa, Y., Kimura, K., Mori, A., Seto, Y., & Ushijima, T. (2019) · Oncogene · doi:10.1038/s41388-019-0792-8 · Cited by 20
Self-citationChen, D., Yan, Y., Xie, J., Pan, J., Chen, Y., Li, Q., Yuan, Y., Zeng, W., & Xing, W. (2020) · Journal of Cancer · doi:10.7150/jca.46630 · Cited by 20
“Studies have indicated that silencing of tumor suppressor genes (TSGs) by promoter methylation contributes to tumor development [9] that the inactivation of TSGs through the hypermethylation of the 5’-CpG islands in gene promoter regions induces processes such as uncontrolled cell growth, metastasis or apoptosis inhib…”
BackgroundCytostatic drug treatment causes seeding of gene promoter methylation
Bredberg, A. C. A., & Bodmer, W. F. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2006.12.003 · Cited by 19
Medical radiation exposure and human carcinogenesis-genetic and epigenetic mechanisms.
Dinçer, Y., & Sezgin, Z. (2014) · PubMed · doi:10.3967/bes2014.106 · Cited by 21
Hypermethylation of P 15 , P 16 , and E-cadherin genes in ovarian cancer
Moselhy, S. S., Kumosani, T., Kamal, I., Jalal, J., Jabaar, H. S. A., & Dalol, A. (2013) · Toxicology and Industrial Health · doi:10.1177/0748233713484657 · Cited by 18
“Inactivation of p16 and p15 genes is the important step in cancer development (Ushijima, 2005).”
BackgroundRegulation of MUC6 Methylation Correlates with Progression of Gastric Cancer
Shi, D., & Xi, X.-X. (2021) · Yonsei Medical Journal · doi:10.3349/ymj.2021.62.11.1005 · Cited by 18
“Previous studies have concluded that regional hypermethylation occurring preferentially at promoter CpG islands plays a significant role in carcinogenesis 24-26 and results in the inactivation of tumor suppressor genes.”
Infection, Stem Cells and Cancer Signals
Sell, S. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111794295675 · Cited by 19
“On the other hand, in areas where stem cells are affected, the self-renewing stem cells continue to give rise to hypermethylated transit-amplifying cells [91,92].”
BackgroundPredicting DNA methylation status using word composition
Lu, L., Lin, K., Qian, Z., Li, H., Cai, Y., & Li, Y. (2010) · Journal of Biomedical Science and Engineering · doi:10.4236/jbise.2010.37091 · Cited by 18
“DNA methylation patterns are altered in many cancer cells [7-9] since the tumor suppression genes are silenced by the DNA methylation.”
BackgroundDNA Methylation ofGSTP1in Human Prostate Tissues: Pyrosequencing Analysis
Yoon, H. Y., Kim, Y., Kang, H.-W., Kim, W. T., Yun, S. J., Lee, S., Kim, W., & Kim, Y. (2012) · Korean journal of urology · doi:10.4111/kju.2012.53.3.200 · Cited by 18
“going methylation during the early phases of tumorigenesis could potentially be used as markers for identifying individuals at increased risk of developing malignancy or for aiding in the diagnosis of early malignancy, whereas those genes undergoing methylation during the progression of malignancy could potentially be…”
BackgroundMethodInfluentialEpigenetic Markers of Ovarian Cancer
Barton, C. A., Clark, S. J., Hacker, N. F., & O’Brien, P. M. (2008) · Springer eBooks · doi:10.1007/978-0-387-68969-2_4 · Cited by 17
Degree of methylation burden is determined by the exposure period to carcinogenic factors
Takeshima, H., Niwa, T., Toyoda, T., Wakabayashi, M., Yamashita, S., & Ushijima, T. (2016) · Cancer Science · doi:10.1111/cas.13136 · Cited by 18
Self-citationMethylated DLX4 Predicts Response to Pathologic Stage I Non-Small Cell Lung Cancer Resection
Harada, H., Miyamoto, K., Yamashita, Y., Taniyama, K., Ohdan, H., & Okada, M. (2015) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.12.058 · Cited by 17
DNA methylation accumulation and its predetermination of future cancer phenotypes
Kaneda, A., Matsusaka, K., Sakai, E., & Funata, S. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu038 · Cited by 18
“Several methods to search for aberrantly silenced genes in cancer using promoter methylation as a marker have been developed since the 1990s (8).”
MethodDNA methylation pattern of apoptosis‐related genes in ameloblastoma
Costa, S., Nb, P., Pereira, K. M. A., Campos, K., Castro, W., Diniz, M., Gomes, C. C., & Gomez, R. S. (2017) · Oral Diseases · doi:10.1111/odi.12661 · Cited by 17
Emerging impacts of biological methylation on genetic information
Kako, K., Kim, J., & Fukamizu, A. (2018) · The Journal of Biochemistry · doi:10.1093/jb/mvy075 · Cited by 19
“Therefore, aberrant changes in DNA methylation levels and patterns are frequently perturbed in human pathology such as cancer (12) and metabolism-related (13), cardiovascular (14) and neurodegenerative diseases (15).”
BackgroundA Nearly Exhaustive Search for CpG Islands on Whole Chromosomes
Hsieh, F., Chen, S., & Pollard, K. S. (2009) · The International Journal of Biostatistics · doi:10.2202/1557-4679.1158 · Cited by 16
Novel risk markers for gastric cancer screening: Present status and future prospects
Enomoto, S. (2010) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v2.i12.381 · Cited by 16
Metadata
- Authors
- Ushijima, T.
- Affiliations
- National Cancer Center Research Institute (JP)
- Corresponding author
- Ushijima, Toshikazu
- ORCID
- Ushijima, Toshikazu
- Venue
- Nature Reviews Cancer
- Published
- 2005-02-18
- Volume
- 5
- Issue
- 3
- Pages
- 223-231
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1999464755
- Cited by
- 483
- References
- 90
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 9 · 2023: 13 · 2022: 13 · 2021: 4 · 2020: 17 · 2019: 17 · 2018: 9 · 2017: 12 · 2016: 15 · 2015: 25 · 2014: 26 · 2013: 36 · 2012: 30
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- DNA methylation, epigenetic modifications, cancer, tumor suppressor, diagnostic biomarkers, prognostic factors, CpG islands
- MeSH terms
- DNA, Neoplasm, Genetic Markers, Humans, Neoplasms, Promoter Regions, Genetic, Genes, Tumor Suppressor, Genome, CpG Islands, DNA Methylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.